Consume excessive alcohol Have immune dysfunction Are older adults (see below for more on this) Have gastrointestinal disorders
Both diabetes and obesity are flagged as growing public health crises in Canada and around the world that also increase the risk of heart disease, stroke and cancer, and pose a burden on healthcare services
Weight regain after discontinuation is common, particularly without lasting lifestyle changes
Some users report gastrointestinal issues, such as nausea, vomiting, or diarrhea, particularly when starting the treatment
Although vitamin B12 injections may increase energy, restore memory, and improve quality of life for individuals with a deficiency, patients whose vitamin B12 levels are normal will not have improved health from this treatment.
In summary, semaglutide is a glp-1 receptor agonist approved by the tga for Australia